Literature DB >> 6793335

Failure of gastric inhibitory polypeptide to inhibit pentagastrin-stimulated acid secretion in vagotomized human subjects.

T C Simmons, I L Taylor, V Maxwell, J C Brown, M I Grossman.   

Abstract

Five vagotomized male subjects were given graded doses of pentagastrin without and with a background infusion of 2 microgram/kg/hr of gastric inhibitory polypeptide (GIP). An insulin infusion test (0.1 units/kg/hr) showed that the vagotomies were complete. GIP infusion failed to inhibit pentagastrin-stimulated acid and pepsin secretion even though plasma GIP concentration reached a plateau much higher than that measured after ingestion of a meal. We conclude that GIP does not inhibit pentagastrin-stimulated gastric acid secretion in vagotomized human subjects.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6793335     DOI: 10.1007/BF01309494

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  4 in total

1.  Effect of continuous intravenous infusion of insulin versus rapid intravenous injection of insulin on gastric acid secretion in man.

Authors:  O Farooq; J I Isenberg
Journal:  Gastroenterology       Date:  1975-04       Impact factor: 22.682

2.  A modified hemoglobin substrate method for the estimation of pepsin in gastric juice.

Authors:  A Berstad
Journal:  Scand J Gastroenterol       Date:  1970       Impact factor: 2.423

3.  Further purification of a polypeptide demonstrating enterogastrone activity.

Authors:  J C Brown; V Mutt; R A Pederson
Journal:  J Physiol       Date:  1970-07       Impact factor: 5.182

4.  Effect of gastric inhibitory polypeptide on pentagastrin-stimulated acid secretion in man.

Authors:  V Maxwell; A Shulkes; J C Brown; T E Solomon; J H Walsh; M I Grossman
Journal:  Dig Dis Sci       Date:  1980-02       Impact factor: 3.199

  4 in total
  1 in total

1.  Inhibitory effect of intragastric glucose on gastric acid secretion and gastric emptying of liquids in man. Role of endogenous somatostatin, gastrin, and insulin.

Authors:  H Sasaki; M Nagulesparan; A Dubois; B Vasquez; E Straus; M L Sievers; R H Unger
Journal:  Dig Dis Sci       Date:  1983-06       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.